Our Story
Why this exists.
A short catalogue, one molecule, and a set of decisions that all point the same way. This is what those decisions were and why we made them.
The shelf was already full
NAD+ is on the front of a lot of bottles, and almost none of them hold it. They hold a precursor, something the body can build NAD+ from, because NAD+ itself is large and fragile and most of an oral dose is taken apart before it reaches the blood. Feeding the body a precursor is a reasonable approach that leaves the building to your cells. What we put in the vial is NAD+ itself, the coenzyme those precursors get built into.
So the form followed the molecule
Once we took the delivery problem seriously, the product stopped being a bottle. A molecule that does not survive the gut has to be kept cold, kept sealed, and given as an injection, and each of those needs is a thing in the box. So the kit is a pre-mixed 1000mg vial of NAD+, a reusable metal auto-injector, and the single-use needles and wipes that a month of it takes.
Three things, and nothing else
The whole catalogue is that kit and the two parts of it that run out, the needles and the wipes. We could add a capsule, a powder and a topical tomorrow, and every one of them would stretch the single claim we can stand behind. So the range stays at a single kit, and that kit is made in the UK.
The certificate goes in the box
Every batch is measured by an independent laboratory before it ships, by HPLC, and it has to come back at 99% NAD+ or higher. That figure is the batch's own result, not a target it was expected to meet. The certificate that carries it does not wait to be asked for: it travels in the box, with the batch it belongs to.
And we say what we do not know
Research on NAD+ is active and a lot of it is early, and the science page says exactly that instead of talking around it. It is the same reason there are no customer photographs on this site, no rating we did not earn, and no returns promise invented to fill a gap.
The Science
The long version.
What NAD+ does in a cell, what happens to it as you age, why the route matters, and what the evidence does not yet support.